115 related articles for article (PubMed ID: 32195537)
1. Detection of Circulating Antibodies to p16 Protein-Derived Peptides in Hepatocellular Carcinoma.
Xu Y; Gu L; Wang J; Wang Z; Zhang P; Zhang X
Lab Med; 2020 Nov; 51(6):574-578. PubMed ID: 32195537
[TBL] [Abstract][Full Text] [Related]
2. Change of circulating antibodies against CD25-derived peptide antigen in hepatocellular carcinoma.
Wang J; Xu Y; Zhao H; Zhang X
J Cancer Res Ther; 2017; 13(5):813-816. PubMed ID: 29237909
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer.
Zhang C; Ye L; Guan S; Jin S; Wang W; Sun S; Lee KH; Wei J; Liu B
Tumour Biol; 2014 Mar; 35(3):2047-51. PubMed ID: 24122232
[TBL] [Abstract][Full Text] [Related]
4. Further Study of Circulating Antibodies to P16, CD25 and FOXP3 in Hepatocellular Carcinoma.
Wang J; Xu Y; Wang Y; Zhang X; Zhang G
Onco Targets Ther; 2019; 12():10487-10493. PubMed ID: 31819529
[TBL] [Abstract][Full Text] [Related]
5. Early detection of hepatocellular carcinoma using autoantibody profiles from a panel of tumor-associated antigens.
Koziol JA; Imai H; Dai L; Zhang JY; Tan EM
Cancer Immunol Immunother; 2018 May; 67(5):835-841. PubMed ID: 29497780
[TBL] [Abstract][Full Text] [Related]
6. Six autoantibodies as potential serum biomarkers of hepatocellular carcinoma: A prospective multicenter study.
Okada R; Otsuka Y; Wakabayashi T; Shinoda M; Aoki T; Murakami M; Arizumi S; Yamamoto M; Aramaki O; Takayama T; Wakiyama S; Yanaga K; Amikura K; Kaneko H; Shimada H
Int J Cancer; 2020 Nov; 147(9):2578-2586. PubMed ID: 32574375
[TBL] [Abstract][Full Text] [Related]
7. Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma.
Hwang HM; Heo CK; Lee HJ; Kwak SS; Lim WH; Yoo JS; Yu DY; Lim KJ; Kim JY; Cho EW
J Transl Med; 2018 Jun; 16(1):177. PubMed ID: 29954402
[TBL] [Abstract][Full Text] [Related]
8. Serum autoantibody measurement for the detection of hepatocellular carcinoma.
Middleton CH; Irving W; Robertson JF; Murray A; Parsy-Kowalska CB; Macdonald IK; McElveen J; Allen J; Healey GF; Thomson BJ; Ryder SJ; Holdenrieder S; Chapman CJ
PLoS One; 2014; 9(8):e103867. PubMed ID: 25093332
[TBL] [Abstract][Full Text] [Related]
9. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
Feng H; Li B; Li Z; Wei Q; Ren L
BMC Cancer; 2021 Apr; 21(1):401. PubMed ID: 33849479
[TBL] [Abstract][Full Text] [Related]
10. Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma.
Ma Y; Qiu C; Wang B; Zhang X; Wang X; Aguilera RJ; Zhang JY
Cells; 2022 Oct; 11(20):. PubMed ID: 36291095
[TBL] [Abstract][Full Text] [Related]
11. Development of a panel of serum IgG and IgA autoantibodies for early diagnosis of colon cancer.
Chen M; Lin X; Zhang L; Yu L; Wu Q; Zhang S; Xue F; Huang Y
Int J Med Sci; 2020; 17(17):2744-2750. PubMed ID: 33162802
[No Abstract] [Full Text] [Related]
12. Anti-p16 autoantibodies may be a useful biomarker for early diagnosis of esophageal cancer.
Jin Y; Guan S; Liu L; Sun S; Lee KH; Wei J
Asia Pac J Clin Oncol; 2015 Dec; 11(4):e37-41. PubMed ID: 24811068
[TBL] [Abstract][Full Text] [Related]
13. Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies.
Looi K; Megliorino R; Shi FD; Peng XX; Chen Y; Zhang JY
Oncol Rep; 2006 Nov; 16(5):1105-10. PubMed ID: 17016600
[TBL] [Abstract][Full Text] [Related]
14. Cyclic Peptide Mimotopes for the Detection of Serum Anti-ATIC Autoantibody Biomarker in Hepato-Cellular Carcinoma.
Heo CK; Hwang HM; Lim WH; Lee HJ; Yoo JS; Lim KJ; Cho EW
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352757
[TBL] [Abstract][Full Text] [Related]
15. Calreticulin is a B cell molecular target in some gastrointestinal malignancies.
Pekáriková A; Sánchez D; Palová-Jelínková L; Simsová M; Benes Z; Hoffmanová I; Drastich P; Janatková I; Mothes T; Tlaskalová-Hogenová H; Tucková L
Clin Exp Immunol; 2010 May; 160(2):215-22. PubMed ID: 20030668
[TBL] [Abstract][Full Text] [Related]
16. Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma.
Liu M; Varela-Ramirez A; Li J; Dai L; Aguilera RJ; Zhang JY
Oncol Rep; 2015 May; 33(5):2245-52. PubMed ID: 25779011
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of plasma HSP90α levels for detection of hepatocellular carcinoma.
Wei W; Liu M; Ning S; Wei J; Zhong J; Li J; Cai Z; Zhang L
BMC Cancer; 2020 Jan; 20(1):6. PubMed ID: 31898536
[TBL] [Abstract][Full Text] [Related]
18. Autoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma.
Liu M; Zheng SJ; Chen Y; Li N; Ren PF; Dai LP; Duan ZP; Zhang JY
J Immunol Res; 2014; 2014():906532. PubMed ID: 24955377
[TBL] [Abstract][Full Text] [Related]
19. Circulating antibodies to p16 protein-derived peptides in breast cancer.
Chen C; Huang Y; Zhang C; Liu T; Zheng HE; Wan S; Sun S; Meng Q; Chen Y; Wei J
Mol Clin Oncol; 2015 May; 3(3):591-594. PubMed ID: 26137272
[TBL] [Abstract][Full Text] [Related]
20. Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma.
Cao B; Yang L; Rong W; Feng L; Han N; Zhang K; Cheng S; Wu J; Xiao T; Gao Y
Int J Clin Exp Pathol; 2015; 8(12):16046-54. PubMed ID: 26884881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
